▶ 調査レポート

獣医分子診断の世界市場2020-2030:製品別(機器・ソフトウェア、キット・試薬、サービス)、技術別、疾患別、動物別、エンドユーザー別

• 英文タイトル:Veterinary Molecular Diagnostics Market (Product Type: Instruments & Software, Kits & Reagents, and Services; Technology: Conventional PCR, Singleplex PCR, Multiplex PCR, Real-time PCR, and Others; Disease Type: Vector-borne Diseases, Respiratory Pathogens, Diarrhea Pathogens, and Others; Animal Type: Companion Animal and Livestock Animal; and End User: Hospitals/Clinics and Reference Laboratories) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

Transparency Market Researchが調査・発行した産業分析レポートです。獣医分子診断の世界市場2020-2030:製品別(機器・ソフトウェア、キット・試薬、サービス)、技術別、疾患別、動物別、エンドユーザー別 / Veterinary Molecular Diagnostics Market (Product Type: Instruments & Software, Kits & Reagents, and Services; Technology: Conventional PCR, Singleplex PCR, Multiplex PCR, Real-time PCR, and Others; Disease Type: Vector-borne Diseases, Respiratory Pathogens, Diarrhea Pathogens, and Others; Animal Type: Companion Animal and Livestock Animal; and End User: Hospitals/Clinics and Reference Laboratories) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030 / MRC20A39資料のイメージです。• レポートコード:MRC20A39
• 出版社/出版日:Transparency Market Research / 2020年10月30日
• レポート形態:英文、PDF、250ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥857,660 (USD5,795)▷ お問い合わせ
  Multi User¥1,301,660 (USD8,795)▷ お問い合わせ
  Corporate License¥1,745,660 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートは、獣医分子診断の世界市場について調査し、序論、仮定/調査手法、エグゼクティブサマリー、市場概要、市場展望、製品別(機器・ソフトウェア、キット・試薬、サービス)分析、技術別分析、疾患別分析、動物別分析、エンドユーザー別分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ)分析、競争状況などを掲載しています。
・序論
・仮定/調査手法
・エグゼクティブサマリー
・市場概要
・市場展望
・獣医分子診断の世界市場規模:製品別(機器・ソフトウェア、キット・試薬、サービス)
・獣医分子診断の世界市場規模:技術別
・獣医分子診断の世界市場規模:疾患別
・獣医分子診断の世界市場規模:動物別
・獣医分子診断の世界市場規模:エンドユーザー別
・獣医分子診断の世界市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ)
・競争状況

Veterinary Molecular Diagnostics Market – Scope of the Report

TMR’s report on the global veterinary molecular diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators for the market during the forecast period from 2020 to 2030. The report provides revenue of the global veterinary molecular diagnostics market for the period 2018–2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global veterinary molecular diagnostics market from 2020 to 2030.

The report is prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the veterinary molecular diagnostics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global veterinary molecular diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global veterinary molecular diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global veterinary molecular diagnostics market.

The report delves into the competition landscape of the global veterinary molecular diagnostics market. Key players operating in the global veterinary molecular diagnostics market are identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global veterinary molecular diagnostics market profiled in this report.

Key Questions Answered in Veterinary Molecular Diagnostics Market Report

What is the sales/revenue generated by veterinary molecular diagnostics across all regions during the forecast period?
What are the opportunities in the global veterinary molecular diagnostics market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which product type segment is expected to generate the highest revenue globally in 2030? Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Veterinary Molecular Diagnostics Market – Research Objectives and Research Approach

The comprehensive report on the global veterinary molecular diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global veterinary molecular diagnostics market in terms of product type, technology, disease type, animal type, end user, and region. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2030 has also been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global veterinary molecular diagnostics market.

レポート目次

1. Preface

1.1. Report Scope and Market Segmentation

1.2. Research Highlights

2. Assumptions and Research Methodology

2.1. Assumptions and Acronyms Used

2.2. Research Methodology

3. Executive Summary

4. Market Overview

4.1. Introduction

4.2. Key Industry Developments

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunity

4.4. Global Veterinary Molecular Diagnostics Market Forecast

4.5. Global Veterinary Molecular Diagnostics Market Outlook

5. Market Outlook

5.1. Key Industrial Events (Licensing Partnership/Merger & Acquisition)

5.2. Pet Ownership Statistics

5.3. List of Pathogens for responsible for Canine, Feline, and Equine Diseases

5.4. Covid-19 Impact Analysis

5.5. Pros and Cons of Each Type of PCR Test

5.6. Technological Advancement

5.7. Most commonly Used Instruments for Veterinary Diagnostics

5.8. Veterinary Medical Device Regulation

6. Global Veterinary Molecular Diagnostics Market Analysis, by Product Type

6.1. Introduction

6.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type

6.3. Global Veterinary Molecular Diagnostics Market Forecast, by Product Type

6.3.1. Instruments & Software

6.3.2. Kits & Reagents

6.3.3. Services

6.4. Global Veterinary Molecular Diagnostics Market Analysis, by Product Type

7. Global Veterinary Molecular Diagnostics Market Analysis, by Technology

7.1. Introduction

7.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology

7.3. Global Veterinary Molecular Diagnostics Market Forecast, by Technology

7.3.1. Conventional PCR

7.3.2. Singleplex PCR

7.3.3. Multiplex PCR

7.3.4. Real-time PCR

7.3.5. Others

7.4. Global Veterinary Molecular Diagnostics Market Analysis, by Technology

8. Global Veterinary Molecular Diagnostics Market Analysis, by Disease Type

8.1. Introduction

8.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type

8.3. Global Veterinary Molecular Diagnostics Market Forecast, by Disease Type

8.3.1. Vector-borne Diseases

8.3.2. Respiratory Pathogens

8.3.3. Diarrhea Pathogens

8.3.4. Others

8.4. Global Veterinary Molecular Diagnostics Market Analysis, by Disease Type

9. Global Veterinary Molecular Diagnostics Market Analysis, by Animal Type

9.1. Introduction

9.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type

9.3. Global Veterinary Molecular Diagnostics Market Forecast, by Animal Type

9.3.1. Companion Animals

9.3.1.1. Canine

9.3.1.2. Feline

9.3.1.3. Others

9.3.2. Livestock Animals

9.4. Global Veterinary Molecular Diagnostics Market Analysis, by Animal Type

10. Global Veterinary Molecular Diagnostics Market Analysis, by End-user

10.1. Introduction

10.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user

10.3. Global Veterinary Molecular Diagnostics Market Forecast, by End-user

10.3.1. Hospitals/Clinics

10.3.2. Reference Laboratories

10.4. Global Veterinary Molecular Diagnostics Market Analysis, by End-user

11. Global Veterinary Molecular Diagnostics Market Analysis, by Region

11.1. Global Veterinary Molecular Diagnostics Market Scenario, by Region/Country

11.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Region

11.3. Global Veterinary Molecular Diagnostics Market Forecast, by Region

11.3.1. North America

11.3.2. Europe

11.3.3. Asia Pacific

11.3.4. Latin America

11.3.5. Middle East & Africa

12. North America Veterinary Molecular Diagnostics Market Analysis

12.1. North America Veterinary Molecular Diagnostics Market Overview

12.2. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Country

12.3. North America Veterinary Molecular Diagnostics Market Forecast, by Country

12.3.1. U.S.

12.3.2. Canada

12.4. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type

12.5. North America Veterinary Molecular Diagnostics Market Forecast, by Product Type

12.5.1. Instruments & Software

12.5.2. Kits & Reagents

12.5.3. Services

12.6. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology

12.7. North America Veterinary Molecular Diagnostics Market Forecast, by Technology

12.7.1. Conventional PCR

12.7.2. Singleplex PCR

12.7.3. Multiplex PCR

12.7.4. Real-time PCR

12.7.5. Others

12.8. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type

12.9. North America Veterinary Molecular Diagnostics Market Forecast, by Disease Type

12.9.1. Vector-borne Diseases

12.9.2. Respiratory Pathogens

12.9.3. Diarrhea Pathogens

12.9.4. Others

12.10. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type

12.11. North America Veterinary Molecular Diagnostics Market Forecast, by Animal Type

12.11.1. Companion Animals

12.11.1.1. Canine

12.11.1.2. Feline

12.11.1.3. Others

12.11.2. Livestock Animals

12.12. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user

12.13. North America Veterinary Molecular Diagnostics Market Forecast, by End-user

12.13.1. Hospitals/Clinics

12.13.2. Reference Laboratories

13. Europe Veterinary Molecular Diagnostics Market Analysis

13.1. Europe Veterinary Molecular Diagnostics Market Overview

13.2. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Country/Sub-region

13.3. Europe Veterinary Molecular Diagnostics Market Forecast, by Country/Sub-region

13.3.1. Germany

13.3.2. U.K.

13.3.3. France

13.3.4. Italy

13.3.5. Spain

13.3.6. Rest of Europe

13.4. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type

13.5. Europe Veterinary Molecular Diagnostics Market Forecast, by Product Type

13.5.1. Instruments & Software

13.5.2. Kits & Reagents

13.5.3. Services

13.6. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology

13.7. Europe Veterinary Molecular Diagnostics Market Forecast, by Technology

13.7.1. Conventional PCR

13.7.2. Singleplex PCR

13.7.3. Multiplex PCR

13.7.4. Real-time PCR

13.7.5. Others

13.8. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type

13.9. Europe Veterinary Molecular Diagnostics Market Forecast, by Disease Type

13.9.1. Vector-borne Diseases

13.9.2. Respiratory Pathogens

13.9.3. Diarrhea Pathogens

13.9.4. Others

13.10. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type

13.11. Europe Veterinary Molecular Diagnostics Market Forecast, by Animal Type

13.11.1. Companion Animals

13.11.1.1. Canine

13.11.1.2. Feline

13.11.1.3. Others

13.11.2. Livestock Animals

13.12. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user

13.13. Europe Veterinary Molecular Diagnostics Market Forecast, by End-user

13.13.1. Hospitals/Clinics

13.13.2. Reference Laboratories

14. Asia Pacific Veterinary Molecular Diagnostics Market Analysis

14.1. Asia Pacific Veterinary Molecular Diagnostics Market Overview

14.2. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Country/Sub-region

14.3. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by Country/Sub-region

14.3.1. China

14.3.2. Japan

14.3.3. India

14.3.4. Australia & New Zealand

14.3.5. Rest of Asia Pacific

14.4. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type

14.5. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by Product Type

14.5.1. Instruments & Software

14.5.2. Kits & Reagents

14.5.3. Services

14.6. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology

14.7. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by Technology

14.7.1. Conventional PCR

14.7.2. Singleplex PCR

14.7.3. Multiplex PCR

14.7.4. Real-time PCR

14.7.5. Others

14.8. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type

14.9. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by Disease Type

14.9.1. Vector-borne Diseases

14.9.2. Respiratory Pathogens

14.9.3. Diarrhea Pathogens

14.9.4. Others

14.10. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type

14.11. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by Animal Type

14.11.1. Companion Animals

14.11.1.1. Canine

14.11.1.2. Feline

14.11.1.3. Others

14.11.2. Livestock Animals

14.12. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user

14.13. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by End-user

14.13.1. Hospitals/Clinics

14.13.2. Reference Laboratories

15. Latin America Veterinary Molecular Diagnostics Market Analysis

15.1. Latin America Veterinary Molecular Diagnostics Market Overview

15.2. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Country/Sub-region

15.3. Latin America Veterinary Molecular Diagnostics Market Forecast, by Country/Sub-region

15.3.1. Brazil

15.3.2. Mexico

15.3.3. Rest of Latin America

15.4. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type

15.5. Latin America Veterinary Molecular Diagnostics Market Forecast, by Product Type

15.5.1. Instruments & Software

15.5.2. Kits & Reagents

15.5.3. Services

15.6. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology

15.7. Latin America Veterinary Molecular Diagnostics Market Forecast, by Technology

15.7.1. Conventional PCR

15.7.2. Singleplex PCR

15.7.3. Multiplex PCR

15.7.4. Real-time PCR

15.7.5. Others

15.8. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type

15.9. Latin America Veterinary Molecular Diagnostics Market Forecast, by Disease Type

15.9.1. Vector-borne Diseases

15.9.2. Respiratory Pathogens

15.9.3. Diarrhea Pathogens

15.9.4. Others

15.10. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type

15.11. Latin America Veterinary Molecular Diagnostics Market Forecast, by Animal Type

15.11.1. Companion Animals

15.11.1.1. Canine

15.11.1.2. Feline

15.11.1.3. Others

15.11.2. Livestock Animals

15.12. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user

15.13. Latin America Veterinary Molecular Diagnostics Market Forecast, by End-user

15.13.1. Hospitals/Clinics

15.13.2. Reference Laboratories

16. Middle East & Africa Veterinary Molecular Diagnostics Market Analysis

16.1. Middle East & Africa Veterinary Molecular Diagnostics Market Overview

16.2. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Country/Sub-region

16.3. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by Country/Sub-region

16.3.1. GCC Countries

16.3.2. South Africa

16.3.3. Rest of Middle East & Africa

16.4. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type

16.5. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by Product Type

16.5.1. Instruments & Software

16.5.2. Kits & Reagents

16.5.3. Services

16.6. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology

16.7. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by Technology

16.7.1. Conventional PCR

16.7.2. Singleplex PCR

16.7.3. Multiplex PCR

16.7.4. Real-time PCR

16.7.5. Others

16.8. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type

16.9. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by Disease Type

16.9.1. Vector-borne Diseases

16.9.2. Respiratory Pathogens

16.9.3. Diarrhea Pathogens

16.9.4. Others

16.10. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type

16.11. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by Animal Type

16.11.1. Companion Animals

16.11.1.1. Canine

16.11.1.2. Feline

16.11.1.3. Others

16.11.2. Livestock Animals

16.12. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user

16.13. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by End-user

16.13.1. Hospitals/Clinics

16.13.2. Reference Laboratories

17. Competition Landscape

17.1. Competition Matrix

17.2. Global Veterinary Molecular Diagnostics Market Share Analysis, by Company

17.3. Company Profiles

17.3.1. IDEXX Laboratories, Inc.

17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

17.3.1.2. Financial Overview

17.3.1.3. Product Portfolio

17.3.1.4. SWOT Analysis

17.3.1.5. Strategic Overview

17.3.2. Thermo Fisher Scientific, Inc.

17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

17.3.2.2. Financial Overview

17.3.2.3. Product Portfolio

17.3.2.4. SWOT Analysis

17.3.2.5. Strategic Overview

17.3.3. Zoetis, Inc.

17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

17.3.3.2. Financial Overview

17.3.3.3. Product Portfolio

17.3.3.4. SWOT Analysis

17.3.3.5. Strategic Overview

17.3.4. Neogen Corporation

17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

17.3.4.2. Product Portfolio

17.3.4.3. SWOT Analysis

17.3.4.4. Strategic Overview

17.3.5. bioMérieux SA

17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

17.3.5.2. Financial Overview

17.3.5.3. Product Portfolio

17.3.5.4. SWOT Analysis

17.3.5.5. Strategic Overview

17.3.6. QIAGEN N.V.

17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

17.3.6.2. Financial Overview

17.3.6.3. Product Portfolio

17.3.6.4. SWOT Analysis

17.3.6.5. Strategic Overview

17.3.7. Biomedica Medizinprodukte GmbH & Co KG

17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

17.3.7.2. Product Portfolio

17.3.7.3. SWOT Analysis

17.3.7.4. Strategic Overview

17.3.8. Bioneer

17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

17.3.8.2. Product Portfolio

17.3.8.3. SWOT Analysis

17.3.8.4. Strategic Overview

17.3.9. VCA, Inc. (subsidiary of Mars, Incorporated)

17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

17.3.9.2. Product Portfolio

17.3.9.3. SWOT Analysis

17.3.9.4. Strategic Overview

17.3.10. ID.VET

17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

17.3.10.2. Product Portfolio

17.3.10.3. SWOT Analysis

17.3.10.4. Strategic Overview

List of Tables

Table 01: Global Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2018–2030

Table 02: Global Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2018–2030

Table 03: Global Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2018–2030

Table 04: Global Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

Table 05: Global Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Companion Animal, 2018–2030

Table 06: Global Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 07: Global Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 08: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Country, 2018–2030

Table 09: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2018–2030

Table 10: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2018–2030

Table 11: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2018–2030

Table 12: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

Table 13: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Companion Animal, 2018–2030

Table 14: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 15: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Countries/Sub-region, 2018–2030

Table 16: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2018–2030

Table 17: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2018–2030

Table 18: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2018–2030

Table 19: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

Table 20: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Companion Animal, 2018–2030

Table 21: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 22: Asia Pacific Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Countries/Sub-region, 2018–2030

Table 23: Asia Pacific Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2018–2030

Table 24: Asia Pacific Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2018–2030

Table 25: Asia Pacific Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2018–2030

Table 26: Asia Pacific Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

Table 27: Asia Pacific Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Companion Animal, 2018–2030

Table 28: Asia Pacific Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 29: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Countries/Sub-region, 2018–2030

Table 30: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2018–2030

Table 31: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2018–2030

Table 32: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2018–2030

Table 33: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

Table 34: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Companion Animal, 2018–2030

Table 35: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 36: Middle East & Africa Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Countries/Sub-region, 2018–2030

Table 37: Middle East & Africa Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2018–2030

Table 38: Middle East & Africa Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2018–2030

Table 39: Middle East & Africa Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2018–2030

Table 40: Middle East & Africa Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

Table 41: Middle East & Africa Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Companion Animal, 2018–2030

Table 42: Middle East & Africa Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030